Colgate-Palmolive Company (CL) Income Statement
CL 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsCL revenue and net income
Where CL's revenue goes
2025Each bar shows an amount and its share of revenue. CL kept 10.5% of revenue as net income.
CL profit margins
CL growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +1.4% | +4.3% | +4.4% | +2.4% |
| Gross profit | +1.2% | +6.5% | +4.3% | +2.7% |
| Operating income | −24.6% | −2.7% | −3.3% | −1.8% |
| Net income | −26.2% | +6.1% | −4.6% | +4.4% |
| EPS (diluted) | +2.8% | +7.5% | +3.9% | +2.8% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
CL quarterly EPS vs estimates
Colgate-Palmolive beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: October 30, 2026 (estimate $0.92).
CL income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.38B | $20.10B | $19.46B | $17.97B | $17.42B | $16.47B | $15.69B | $15.54B | $15.45B | $15.20B |
| Cost of revenue | $8.13B | $8.00B | $8.21B | $7.82B | $7.13B | $6.54B | $6.42B | $6.34B | $6.13B | $6.06B |
| Gross profit | $12.25B | $12.11B | $11.25B | $10.15B | $10.29B | $9.93B | $9.28B | $9.21B | $9.32B | $9.13B |
| Research & development | $366.0M | $355.0M | $343.0M | $320.0M | $307.0M | $290.0M | $281.0M | $277.0M | $285.0M | $289.0M |
| Sales, general & admin | $7.89B | $5.09B | $4.87B | $4.57B | $4.41B | $4.07B | $3.88B | $3.84B | $3.84B | $3.74B |
| Total operating expenses | $8.95B | $7.72B | $7.12B | $6.57B | $6.41B | $6.02B | $5.51B | $5.36B | $5.31B | $5.17B |
| Operating income | $3.31B | $4.38B | $4.13B | $3.58B | $3.89B | $3.91B | $3.76B | $3.85B | $4.01B | $3.96B |
| Interest income | $192.0M | $67.0M | $55.0M | $153.0M | $175.0M | $164.0M | $47.0M | $50.0M | $51.0M | $50.0M |
| Interest expense | $267.0M | $292.0M | $287.0M | $167.0M | $117.0M | $160.0M | $192.0M | $193.0M | $153.0M | $149.0M |
| Income before taxes | $3.06B | $3.96B | $3.39B | $2.66B | $3.09B | $3.65B | $3.30B | $3.46B | $3.49B | $3.74B |
| Income taxes | $798.0M | $907.0M | $937.0M | $693.0M | $749.0M | $787.0M | $774.0M | $906.0M | $1.31B | $1.15B |
| Net income | $2.13B | $2.89B | $2.30B | $1.78B | $2.17B | $2.69B | $2.37B | $2.40B | $2.02B | $2.44B |
| EBITDA | $4.87B | $4.85B | $4.25B | $3.37B | $3.76B | $4.35B | $4.01B | $4.17B | $4.12B | $4.33B |
| EPS (diluted) | $3.69 | $3.59 | $3.23 | $2.97 | $3.20 | $3.05 | $2.83 | $2.97 | $2.87 | $2.81 |
| Gross margin | 60.1% | 60.2% | 57.8% | 56.5% | 59.1% | 60.3% | 59.1% | 59.2% | 60.3% | 60.1% |
| Operating margin | 16.2% | 21.8% | 21.2% | 20.0% | 22.3% | 23.7% | 24.0% | 24.8% | 25.9% | 26.1% |
| Net margin | 10.5% | 14.4% | 11.8% | 9.9% | 12.4% | 16.4% | 15.1% | 15.4% | 13.1% | 16.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.36B | $5.32B | $5.23B | $5.13B | $5.11B | $4.91B | $4.94B | $5.03B | $5.06B | $5.07B | $4.95B | $4.92B |
| Cost of revenue | $2.06B | $2.10B | $2.08B | $2.08B | $2.04B | $1.92B | $1.96B | $1.96B | $1.99B | $2.03B | $2.01B | $2.03B |
| Gross profit | $3.30B | $3.23B | $3.15B | $3.05B | $3.07B | $2.99B | $2.98B | $3.07B | $3.07B | $3.04B | $2.94B | $2.88B |
| Research & development | — | — | — | — | — | — | $355.0M | — | — | — | $343.0M | — |
| Sales, general & admin | $2.13B | $2.08B | $1.98B | $1.32B | $1.99B | $1.91B | $1.27B | $2.00B | $1.25B | $1.26B | $1.21B | $1.82B |
| Total operating expenses | $2.28B | $2.08B | $2.07B | $1.95B | $1.99B | $1.91B | $1.89B | $1.96B | $1.91B | $1.86B | $1.80B | $1.82B |
| Operating income | $1.02B | $1.16B | $1.08B | $1.10B | $1.08B | $1.08B | $1.09B | $1.11B | $1.16B | $1.18B | $1.14B | $1.06B |
| Interest income | $17.0M | $16.0M | $46.0M | $21.0M | $50.0M | $15.0M | $50.0M | $56.0M | $18.0M | $15.0M | — | $58.0M |
| Interest expense | $62.0M | $62.0M | $64.0M | $67.0M | $71.0M | $66.0M | $66.0M | $56.0M | $62.0M | $58.0M | $62.0M | $60.0M |
| Income before taxes | $950.0M | $892.0M | $107.0M | $992.0M | $1.01B | $953.0M | $994.0M | $986.0M | $1.01B | $967.0M | $988.0M | $956.0M |
| Income taxes | $231.0M | $211.0M | $112.0M | $226.0M | $234.0M | $227.0M | $214.0M | $210.0M | $243.0M | $238.0M | $228.0M | $209.0M |
| Net income | $693.0M | $646.0M | −$37.0M | $735.0M | $743.0M | $690.0M | $739.0M | $737.0M | $731.0M | $683.0M | $718.0M | $708.0M |
| EBITDA | $1.17B | $1.11B | $344.0M | $1.22B | $1.22B | $1.17B | $1.21B | $1.19B | $1.23B | $1.18B | $1.20B | $1.16B |
| EPS (diluted) | $0.99 | $0.97 | $0.95 | $0.91 | $0.92 | $0.91 | $0.91 | $0.91 | $0.91 | $0.86 | $0.87 | $0.86 |
| Gross margin | 61.5% | 60.6% | 60.2% | 59.4% | 60.1% | 60.8% | 60.3% | 61.1% | 60.7% | 59.9% | 59.5% | 58.7% |
| Operating margin | 19.0% | 21.7% | 20.6% | 21.4% | 21.1% | 21.9% | 22.0% | 22.1% | 22.9% | 23.2% | 23.0% | 21.6% |
| Net margin | 12.9% | 12.1% | −0.7% | 14.3% | 14.5% | 14.1% | 14.9% | 14.6% | 14.5% | 13.5% | 14.5% | 14.4% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in CL's financial statements (latest annual report filed February 23, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
CL financial results
In fiscal year 2025 (ended December 31, 2025), Colgate-Palmolive reported revenue of $20.4 billion, up 1.4% from the year before. It had net income of $2.1 billion (down 26.2%), a net profit margin of 10.5%. Diluted earnings per share came to $3.69. Over five years revenue grew at an average rate of 4.4% a year.
See the CL stock overview for the latest quote and news, or the CL chart for price history and technical indicators.
CL income statement FAQ
What is Colgate-Palmolive's annual revenue?
Colgate-Palmolive reported total revenue of $20.4 billion for fiscal year 2025, which ended on December 31, 2025. That was up 1.4% from $20.1 billion the previous year.
Is Colgate-Palmolive profitable?
Yes. Colgate-Palmolive reported net income of $2.1 billion in fiscal 2025, a net profit margin of 10.5%; its operating margin was 16.2%.
What is Colgate-Palmolive's gross margin?
Colgate-Palmolive's gross margin was 60.1% in fiscal 2025: for every $100 of revenue, Colgate-Palmolive kept $60 after the direct cost of its products and services.
How much does Colgate-Palmolive spend on research and development?
Colgate-Palmolive spent $366.0 million on research and development in fiscal 2025, 1.8% of revenue.
How fast is Colgate-Palmolive growing?
Revenue grew 4.4% a year on average over the last five fiscal years, from $16.5 billion to $20.4 billion.
What are Colgate-Palmolive's earnings per share?
Colgate-Palmolive earned $3.69 per diluted share in fiscal 2025, compared with $3.59 a year earlier.
When will Colgate-Palmolive report its next earnings?
Colgate-Palmolive is expected to report results for the quarter ending September 30, 2026 on October 30, 2026 before the market opens.
When does Colgate-Palmolive's fiscal year end?
Colgate-Palmolive's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 23, 2026.